Art

J-GLOBAL ID：201502234471303275   Reference number：15A0513443

Acceleration of Iron Utilization After Intravenous Iron Administration During Activated Erythropoiesis in Hemodialysis Patients: A Randomized Study

血液透析患者の赤血球生成活性化時の静脈内鉄投与後の鉄利用の促進 ランダム化試験

Author (12)： KUJI Tadashi (Yokodai Central Clinic, Yokohama, Kanagawa, Japan; Dep. of Medical Sci. and Cardiorenal Medicine, Yokohama City ...) ,  TOYA Yoshiyuki ,  FUJIKAWA Tetsuya ,  KAKIMOTO-SHINO Midori ,  NISHIHARA Masahiro ,  SHIBATA Kazuhiko ,  TAMURA Kouichi ,  HIRAWA Nobuhito ,  SATTA Hidehisa ,  KAWATA Sei-ichi ,  KOUGUCHI Naoaki ,  UMEMURA Satoshi
Material： Therapeutic Apheresis and Dialysis  (Ther Apheresis Dial)
Volume： 19  Issue： 2  Page： 131-137  Publication year： Apr. 2015 
JST Material Number： W1443A  ISSN： 1744-9979  Document type： Article
Article type： 原著論文  Country of issue： Australia (AUS)  Language： ENGLISH (EN)

Thesaurus term： human ,...
Semi thesaurus term： renal anemia ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=15A0513443&from=J-GLOBAL&jstjournalNo=W1443A") }}

JST classification (3)： Other therapies for urogenital diseases  (GM05040R) ,  Clinical application of drugs acting on blood and body fluid  (GW14020X) ,  Drug therapy(=pharmacotherapy)for hematologic diseases in general  (GK05020P)

Reference (24)：

• Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. The impact of anemia on cardiomyopathy, morbidity and mortality in end-stage renal disease. Am J Kidney Dis 1996;28:53-61.
• Moreno F, Aracil FJ, Perez R, Valderrabano F. Controlled study on the improvement of quality of life in elderly hemodialysis patients after correcting end-stage renal disease-related anemia with erythropoietin. Am J Kidney Dis 1996;27:548-56.
• Mocks J, Franke W, Ehmer B, Scigalla P, Quarder O. Analysis of safety database for long-term epoetin-beta treatment. A metaanalysis covering 3697 patients. In: Koch KM, Stein G, eds. Pathogenetic and Therapeutic Aspects of Chronic Renal Failure. New York: Marcel Dekker, 1997; 163-79.
• Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW. Correction of the anemia of end stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. N Engl J Med 1987;316:73-8.
• López-Gómez JM, Portolés JM, Aljama P. Factors that condition the response to erythropoietin in patients on hemodialysis and their relation to mortality. Kidney Int Suppl 2008;111:S75-81.

Terms in the title (8)： 血液透析患者 ,  赤血球生成 ,  活性化 ,  静脈 ,  鉄 ,  投与 ,  促進 ,  ランダム化試験